Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients
- PMID: 11725816
- DOI: 10.1007/s007020170003
Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients
Abstract
Antioxidant profiles in Parkinson's disease (PD; n = 15), dementias of Alzheimer's type (DAT; 18) and Vascular (VD; 15), and control subjects (C; 14) were studied. Cu-Zn superoxide dismutase (SOD), catalase (CAT), glutathione system (GLU) and thiobarbituric acid reactive substances (TBARS) were measured in erythrocytes; antioxidant capacity (TRAP) in plasma. Biochemical variables were analyzed simultaneously using multi-variate and non-parametric methods. Clinical diagnostic resulted associated with the main source of variability in antioxidant variables (Kruskal-Wallis: H = 32.58, p = 0.000001). Comparison of PD and C resulted highly significant (z = 4.47, p = 0.000047), demonstrating an association between oxidative stress and PD. SOD and TBARS were significantly higher in pathological groups against C (p = 0.0000001, p = 0.051); TRAP resulted lower (p = 0.00015). Discriminant functions constructed using biochemical variables separated pathological groups (93% success) from C, and DAT (88.9%) from VD (73.3%); but not PD from DAT or VD. Antioxidant profiles of PD patients showed characteristics overlapping with DAT (60%) and with VD (40%), suggesting biochemical similarities between them.
Similar articles
-
Oxidative stress in Alzheimer's and vascular dementias: masking of the antioxidant profiles by a concomitant Type II diabetes mellitus condition.J Neurol Sci. 2004 Mar 15;218(1-2):17-24. doi: 10.1016/j.jns.2003.10.004. J Neurol Sci. 2004. PMID: 14759628
-
The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls.J Neurol Sci. 1996 Sep 15;141(1-2):69-78. doi: 10.1016/0022-510x(96)00163-3. J Neurol Sci. 1996. PMID: 8880696
-
Systemic oxidative stress associated with the neurological diseases of aging.Neurochem Res. 2009 Dec;34(12):2122-32. doi: 10.1007/s11064-009-9997-5. Neurochem Res. 2009. PMID: 19488852
-
[Oxidative stress in the neurodegenerative diseases--potential antioxidant activity of catecholamines].Postepy Biochem. 2010;56(3):248-59. Postepy Biochem. 2010. PMID: 21117312 Review. Polish.
-
Can we prevent Parkinson's and Alzheimer's disease?J Postgrad Med. 2003 Jul-Sep;49(3):236-45. J Postgrad Med. 2003. PMID: 14597787 Review.
Cited by
-
Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation.Mol Neurodegener. 2011 May 19;6:34. doi: 10.1186/1750-1326-6-34. Mol Neurodegener. 2011. PMID: 21595948 Free PMC article.
-
The roles of biomarkers of oxidative stress and antioxidant in Alzheimer's disease: a systematic review.Biomed Res Int. 2014;2014:182303. doi: 10.1155/2014/182303. Epub 2014 May 14. Biomed Res Int. 2014. PMID: 24949424 Free PMC article. Review.
-
Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities.Oxid Med Cell Longev. 2022 Feb 21;2022:5288698. doi: 10.1155/2022/5288698. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35237381 Free PMC article. Review.
-
Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):947-56. doi: 10.1002/ajmg.b.30366. Am J Med Genet B Neuropsychiatr Genet. 2006. PMID: 16917939 Free PMC article.
-
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats.Front Pharmacol. 2016 Sep 28;7:343. doi: 10.3389/fphar.2016.00343. eCollection 2016. Front Pharmacol. 2016. PMID: 27733830 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous